Phase 1 clinical trials are in reach that's if the company is...

Phase 1 clinical trials are in reach that's if the company is being honest with its progress and not misleading shareholders.

Phase 1 is usually a small cohert of patients .

Investors would not be an issue if Phase 1 is successful . 

Phase 2a and 2b  is where it becomes alot more expensive and complicated .

They raised 9 million , some of which should be allocated to midkine developments .

If you read back over the years they should of been in clinical trials by now , but you already know that . 

If Cellmid have misled shareholders regarding  midkine developments then a class action is not out of question .